Similarly, treatment with ARV-825 reduced the surface expression of CD44 and increased ROS levels in LPN228 and LPN49, cell lines derived from mouse T-ALL (Fig. S2B). The gene discussed is CD44; the disease is acute lymphoblastic leukemia.